{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:42Z","timestamp":1777564662572,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T00:00:00Z","timestamp":1498521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/51030-4"],"award-info":[{"award-number":["2012\/51030-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11046-017-0165-1","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T09:15:48Z","timestamp":1498554948000},"page":"855-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing\/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient"],"prefix":"10.1007","volume":"182","author":[{"given":"Rodrigo","family":"de Carvalho Santana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia Aparecida","family":"Schiave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alda Soares","family":"dos Santos Quaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane Masetto","family":"de Gaitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,27]]},"reference":[{"issue":"3","key":"165_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(3):291\u2013322.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"165_CR2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","volume":"58","author":"JN Jarvis","year":"2014","unstructured":"Jarvis JN, BicanicT Loyse A, Namarika D, Jackson A, Nussbaum JC, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58(5):736\u201345.","journal-title":"Clin Infect Dis"},{"key":"165_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11046-011-9504-9","volume":"173","author":"DJ Mora","year":"2012","unstructured":"Mora DJ, da Cunha Colombo ER, Ferreira-Paim K, Andrade-Silva LE, Nascentes GA, Silva-Vergara ML. Clinical, epidemiological and outcomes features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. Mycopathologia. 2012;173:321\u20137.","journal-title":"Mycopathologia"},{"issue":"5","key":"165_CR4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4269\/ajtmh.15-0595","volume":"94","author":"E Nascimento","year":"2016","unstructured":"Nascimento E, Vitali LH, Tonani L, Kress MR, Takayanagui OM, Martinez R. Refractory and\/or relapsing cryptococcosis associated with AIDS: clinical features, genotype and virulence factors of Cryptococcus spp. isolates. Am J Trop Med Hyg. 2016;94(5):975\u201381.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"165_CR5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1365-3156.2010.02622.x","volume":"15","author":"E Espi\u00e9","year":"2010","unstructured":"Espi\u00e9 E, Pinoges L, Balkan S, ChanchLaya N, Molfino L, Narom P, Pujades-Rodr\u00edgues M. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia. Trop Med Int Health. 2010;15(11):1375\u201381.","journal-title":"Trop Med Int Health"},{"issue":"3","key":"165_CR6","doi-asserted-by":"crossref","first-page":"e32868","DOI":"10.1371\/journal.pone.0032868","volume":"7","author":"W Pan","year":"2012","unstructured":"Pan W, Khayhan K, Hagen F, Wahyuninqsih R, Chakrabarti A, Chawhary A, et al. Resistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypes. PLoS ONE. 2012;7(3):e32868.","journal-title":"PLoS ONE"},{"key":"165_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12879-015-1023-8","volume":"15","author":"YC Chen","year":"2015","unstructured":"Chen YC, Chang TY, Liu JW, Chen FJ, Chien CC, Lee CH, et al. Increasing trend of fluconazole non susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study. BMC Infect Dis. 2015;15:277.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"165_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.aca.2008.12.006","volume":"634","author":"JL Italia","year":"2009","unstructured":"Italia JL, Singh D, Ravi MNV, Kumar R. High-performance liquid chromatographic analysis of amphotericin B in rat plasma using \u03b1-naphthol as an internal standard. Anal Chim Acta. 2009;634(1):110\u20134.","journal-title":"Anal Chim Acta"},{"issue":"2","key":"165_CR9","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","volume":"4","author":"F Dromer","year":"2007","unstructured":"Dromer F, Mathoulin-P\u00e9llissier S, Launay O, Lortholary O, French Cryptococcosis Study Group, 2007. Determinants of disease presentation and outcome during cryptococcosis: the Crypto A\/D study. PloS Med. 2007;4(2):e21.","journal-title":"PloS Med"},{"issue":"11","key":"165_CR10","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/AAC.01115-12","volume":"56","author":"A Espinel-Ingroff","year":"2012","unstructured":"Espinel-Ingroff A, Aller AI, Canton E, Casta\u00f1\u00f3n-Olivares LR, Chondhary A, Cordoba S, et al. Cryptococcus neoformans\u2013Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole and voriconazole. Antimicrob Agents Chemother. 2012;56(11):5898\u2013906.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"165_CR11","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.00694-13","volume":"57","author":"E Sionov","year":"2013","unstructured":"Sionov E, Chang YC, Kwon-Chung KJ. Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment. Antimicrob Agents Chemother. 2013;57(10):5127\u201330.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"165_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/13693786.2012.715763","volume":"51","author":"JW Cheong","year":"2013","unstructured":"Cheong JW, McCormack J. Fluconazole resistance in cryptococcal disease: emerging or intrinsic? Med Mycol. 2013;51(3):261\u20139.","journal-title":"Med Mycol"},{"key":"165_CR13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","volume":"44","author":"AI Aller","year":"2000","unstructured":"Aller AI, Martin-Mazuelos E, Lorenzo F, Gomez-Mateos J, Steele Moore L, Holloway WJ, et al. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother. 2000;44:1544\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"165_CR14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","volume":"43","author":"T Bicanic","year":"2006","unstructured":"Bicanic T, Harrison T, Niepieklo A, Dyakopu W, Meintjes G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis. 2006;43(8):1069\u201373.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"165_CR15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.riam.2014.07.006","volume":"32","author":"CA Agudelo","year":"2015","unstructured":"Agudelo CA, Mu\u00f1oz C, Ramirez A, Tob\u00f3n AM, de BedouBact C, Cano LE, et al. Response to therapy in patientswith cryptococcosis and AIDS: association with in vitro susceptibility to fluconazole. Rev Iberoam Micol. 2015;32(4):214\u201328.","journal-title":"Rev Iberoam Micol"},{"issue":"7","key":"165_CR16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(13)70078-1","volume":"13","author":"A Loyse","year":"2013","unstructured":"Loyse A, Thangaraj H, Easterbrook P, Ford N, Roy M, Chiller T, Govender N, et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013;13(7):629\u201337.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"165_CR17","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/jac\/dku148","volume":"69","author":"V Strenger","year":"2014","unstructured":"Strenger V, Meinitzer A, Donnerer J, Hofer N, Dornbusch HJ, Wanz U, et al. Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B. J Antimicrob Chemother. 2014;69(4):2522\u20136.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"165_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1399-3046.2005.00434.x","volume":"10","author":"S Cesaro","year":"2006","unstructured":"Cesaro S, Zigmol M, Burlina AB, Tridello G, Visintin G, Messina C. Assessment of nephrotoxicity of high-cumulative dose of liposomal amphotericin B in a pediatric patient who underwent allogeneic bone marrow transplantation. Pediatr Transplant. 2006;10(2):255\u20138.","journal-title":"Pediatr Transplant"},{"issue":"6","key":"165_CR19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ijantimicag.2014.02.015","volume":"43","author":"JM Michot","year":"2014","unstructured":"Michot JM, Gubavu C, Fourn E, Maigne G, Teicher E, Angoulvant A, et al. Very prolonged liposomal amphotericin B use leading to a lysosomal storage disease. Int J Antimicrob Agents. 2014;43(6):566\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"165_CR20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","volume":"46","author":"I Bekersky","year":"2012","unstructured":"Bekersky I, Fielding RM, Dressler DE, Lee JW, Buell DN, Walsh TJ. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B, (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother. 2012;46(3):828\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"165_CR21","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/AAC.42.9.2391","volume":"42","author":"TJ Walsh","year":"1998","unstructured":"Walsh TJ, Yeldandi V, McEvoy M, Gonzalez C, ChaNock S, Freifield A, et al. Safety, tolerance and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob Agents Chemother. 1998;42(9):2391\u20138.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-017-0165-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-017-0165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-017-0165-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T02:12:43Z","timestamp":1569550363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-017-0165-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,27]]},"references-count":21,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1007\/s11046-017-0165-1","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,27]]}}}